Also see: FedEx, UPS: Analysts' New Ratings
Editor's Note: Green and red arrows refer to intraday stock price movement.
NEW YORK (
STOCK COMMENTS / EPS CHANGES
target lowered at KeyBanc to $78. Secular drivers in Bromine and Catalysts franchises should offset softer demand. Buy rating.
estimates increased at BMO through 2011. Strong August volumes. Maintain $24 price target and Market Perform rating.
estimates, target raised at Citigroup. Shares of CIEN now seen reaching $18. Estimates also increased as results guide soft, but not as bad as feared. Buy rating.
Ciena estimates boosted at Morgan Stanley through 2013. Company is cutting operating costs. Equal-weight rating.
estimates increased at Credit Suisse through 2013. Student loan purchase should add to earnings. Neutral rating and $28 price target.
numbers reduced at Credit Suisse. Shares of ESL now seen reaching $87. Company lowered its guidance. Outperform rating.
Esterline Technologies estimates, target cut at Jefferies. Shares of ESL now seen reaching $84. Estimates also lowered as Q3 results contained more noise than expected.
estimates, target adjusted at UBS. Shares of FL now seen reaching $22. Estimates increased on impressive SSS and margin improvements. Neutral rating.
estimates raised at Morgan Stanley through 2014. Company is seeing higher order growth. Overweight rating and $22 price target.
estimates cut at Credit Suisse through 2013. Company is facing several potential growth headwinds. Outperform rating and $170 price target.
estimates lowered at Oppenheimer through 2012. Relatively in line, but seasonally soft F1Q12. Maintain Perform rating.
estimates trimmed at Sterne Agee through 2013. Valuation call. Maintain Neutral rating.
estimates increased at Goldman through 2013. OXPS purchase should add to earnings. Neutral rating and $14 price target.
estimates cut at JP Morgan. TGT estimates were reduced through 2012. Credit card business is a drag on profits. Overweight rating and $58 price target.
estimates reduced at JMP through 2012. Company has low order visibility. Market Perform rating.
estimates upped at Morgan Stanley through 2013. Meraux purchase should add to earnings. Equal-weight rating and $29 price target.
End of report.
This article was written by a staff member of TheStreet.